peptide pools
6 articles tagged with ‘peptide pools’
Cell Signaling Peptides and Peptide Pools for Research Applications
Cell signaling peptides and peptide pools are essential tools for studying cellular communication, growth, differentiation, and stress responses. This article explores their roles in neuroprotective signaling, cardiovascular regulation, and more, and highlights how researchers can use them to dissect complex molecular networks.
Peptide Drug Research: Infectious Disease Peptides and Peptide Pools
Peptide drugs are short chains of amino acids used in research to target specific biological pathways. This article explains how peptide pools enable epitope discovery, immune monitoring, and vaccine development for viral, bacterial, and fungal infectious diseases. Learn about key applications and how to verify peptide quality for reproducible research.
Peptide Therapy in Research: How Peptide Pools Advance Immunology Studies
Peptide therapy research relies on high-quality tools like ready-to-use peptide pools. This article explains how 15-mer peptides overlapping by 11 amino acids provide broad antigen coverage, stimulate up to 2.5 × 10⁸ cells per unit, and support epitope discovery, vaccine development, and T-cell therapy studies. Learn what to look for when sourcing peptide pools for your lab.
Ozempic in Peptide Research: Context, Tools, and Validation
Ozempic is a GLP-1 receptor agonist used in metabolic research. This article explains how peptide analysis tools, including standard peptides like α-Casein and carbonic anhydrase peptides, support studies of protein structure and function. Learn about FLAG tag applications and how Volta Peptides resources help verify research compounds.
Varicella Zoster Virus Proteins gE, IE-62, and IE-63 Essential for Infection
Research updates from February 2025 reveal that the Varicella Zoster Virus relies on three key proteins: gE, IE-62, and IE-63. These proteins are essential for membrane fusion, gene transactivation, and immune evasion, providing new targets for antiviral strategies.
Cancer-Testis Antigens: Targets for Immunotherapy Research
Cancer-Testis Antigens (CTAs) are normally restricted to germline tissues like testis or placenta, which are immune-privileged and lack MHC class I expression. Their aberrant expression in various cancers makes them ideal targets for immunotherapy due to minimal expression in normal somatic tissues. This article focuses on two key CTAs, NY-ESO-1 and PRAME, and their roles in T-cell-based immunotherapy.